FONAR Corporation (FONR)
USD 13.49
(-2.25%)
USD 13.49
(-2.25%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 2.71 Million USD | 5.67% |
| 2023 | 2.56 Million USD | 8.89% |
| 2022 | 2.35 Million USD | 41.87% |
| 2021 | 1.66 Million USD | 0.89% |
| 2020 | 1.64 Million USD | -8.31% |
| 2019 | 1.79 Million USD | 25.62% |
| 2018 | 1.43 Million USD | -11.88% |
| 2017 | 1.62 Million USD | -21.7% |
| 2016 | 2.07 Million USD | -5.36% |
| 2015 | 2.19 Million USD | -10.3% |
| 2014 | 2.44 Million USD | 17.64% |
| 2013 | 2.07 Million USD | -5.37% |
| 2012 | 2.19 Million USD | -8.55% |
| 2011 | 2.4 Million USD | -15.07% |
| 2010 | 2.82 Million USD | -10.91% |
| 2009 | 3.17 Million USD | -2.57% |
| 2008 | 3.25 Million USD | -27.09% |
| 2007 | 4.46 Million USD | -36.9% |
| 2006 | 7.07 Million USD | -28.06% |
| 2005 | 9.83 Million USD | 2.63% |
| 2004 | 9.58 Million USD | 89.54% |
| 2003 | 5.05 Million USD | 8.44% |
| 2002 | 4.66 Million USD | 25.19% |
| 2001 | 3.72 Million USD | 5.35% |
| 2000 | 3.53 Million USD | -15.81% |
| 1999 | 4.2 Million USD | 20.0% |
| 1998 | 3.5 Million USD | 2.94% |
| 1997 | 3.4 Million USD | -5.56% |
| 1996 | 3.6 Million USD | 56.52% |
| 1995 | 2.3 Million USD | -17.86% |
| 1994 | 2.8 Million USD | -3.45% |
| 1993 | 2.9 Million USD | -9.38% |
| 1992 | 3.2 Million USD | 6.67% |
| 1991 | 3 Million USD | -26.83% |
| 1990 | 4.1 Million USD | -42.25% |
| 1989 | 7.1 Million USD | 20.34% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 2.93 Million USD | 3.53% |
| 2024 Q2 | 2.83 Million USD | 0.39% |
| 2024 Q1 | 2.82 Million USD | 9.9% |
| 2024 Q4 | 2.71 Million USD | -7.48% |
| 2023 Q4 | 2.56 Million USD | -3.43% |
| 2023 FY | 2.56 Million USD | 8.89% |
| 2023 Q1 | 2.45 Million USD | 4.16% |
| 2023 Q2 | 2.63 Million USD | 7.16% |
| 2023 Q3 | 2.66 Million USD | 1.03% |
| 2022 Q4 | 2.35 Million USD | -0.35% |
| 2022 Q1 | 1.83 Million USD | 10.31% |
| 2022 Q2 | 2.09 Million USD | 14.39% |
| 2022 Q3 | 2.36 Million USD | 12.82% |
| 2022 FY | 2.35 Million USD | 41.87% |
| 2021 Q4 | 1.66 Million USD | -15.61% |
| 2021 Q3 | 1.97 Million USD | 6.89% |
| 2021 Q2 | 1.84 Million USD | 8.6% |
| 2021 Q1 | 1.69 Million USD | 2.99% |
| 2021 FY | 1.66 Million USD | 0.89% |
| 2020 Q2 | 1.75 Million USD | -2.23% |
| 2020 Q3 | 1.77 Million USD | 1.37% |
| 2020 Q4 | 1.64 Million USD | -7.11% |
| 2020 Q1 | 1.79 Million USD | -0.4% |
| 2020 FY | 1.64 Million USD | -8.31% |
| 2019 Q4 | 1.79 Million USD | -0.65% |
| 2019 FY | 1.79 Million USD | 25.62% |
| 2019 Q1 | 1.64 Million USD | 15.2% |
| 2019 Q2 | 1.65 Million USD | 0.49% |
| 2019 Q3 | 1.81 Million USD | 9.23% |
| 2018 Q1 | 1.68 Million USD | 3.92% |
| 2018 Q4 | 1.43 Million USD | -12.56% |
| 2018 Q3 | 1.63 Million USD | -3.48% |
| 2018 Q2 | 1.69 Million USD | 0.47% |
| 2018 FY | 1.43 Million USD | -11.88% |
| 2017 Q1 | 2.21 Million USD | 6.73% |
| 2017 Q2 | 2.73 Million USD | 23.53% |
| 2017 FY | 1.62 Million USD | -21.7% |
| 2017 Q4 | 1.62 Million USD | -39.17% |
| 2017 Q3 | 2.67 Million USD | -2.38% |
| 2016 FY | 2.07 Million USD | -5.36% |
| 2016 Q1 | 2.29 Million USD | 4.75% |
| 2016 Q4 | 2.07 Million USD | -7.15% |
| 2016 Q2 | 2.25 Million USD | -1.61% |
| 2016 Q3 | 2.23 Million USD | -1.11% |
| 2015 FY | 2.19 Million USD | -10.3% |
| 2015 Q2 | 2.36 Million USD | -2.44% |
| 2015 Q3 | 2.28 Million USD | -3.26% |
| 2015 Q1 | 2.42 Million USD | -0.88% |
| 2015 Q4 | 2.19 Million USD | -4.12% |
| 2014 FY | 2.44 Million USD | 17.64% |
| 2014 Q4 | 2.44 Million USD | -2.65% |
| 2014 Q2 | 2.56 Million USD | 20.51% |
| 2014 Q1 | 2.12 Million USD | 2.35% |
| 2014 Q3 | 2.51 Million USD | -2.03% |
| 2013 Q2 | 2.23 Million USD | -11.04% |
| 2013 Q3 | 2.28 Million USD | 2.01% |
| 2013 Q4 | 2.07 Million USD | -9.06% |
| 2013 FY | 2.07 Million USD | -5.37% |
| 2013 Q1 | 2.51 Million USD | 14.67% |
| 2012 Q1 | 3.81 Million USD | 59.03% |
| 2012 Q2 | 3.8 Million USD | -0.29% |
| 2012 Q3 | 3.33 Million USD | -12.35% |
| 2012 Q4 | 2.19 Million USD | -34.2% |
| 2012 FY | 2.19 Million USD | -8.55% |
| 2011 FY | 2.4 Million USD | -15.07% |
| 2011 Q4 | 2.4 Million USD | 9.5% |
| 2011 Q3 | 2.19 Million USD | -20.49% |
| 2011 Q2 | 2.75 Million USD | 8.76% |
| 2011 Q1 | 2.53 Million USD | -10.3% |
| 2010 Q4 | 2.82 Million USD | -3.58% |
| 2010 Q3 | 2.93 Million USD | 3.24% |
| 2010 Q2 | 2.83 Million USD | -17.76% |
| 2010 Q1 | 3.45 Million USD | 8.81% |
| 2010 FY | 2.82 Million USD | -10.91% |
| 2009 Q1 | 3.2 Million USD | -1.66% |
| 2009 Q4 | 3.17 Million USD | -16.36% |
| 2009 FY | 3.17 Million USD | -2.57% |
| 2009 Q2 | 3.85 Million USD | 20.42% |
| 2009 Q3 | 3.79 Million USD | -1.63% |
| 2008 Q2 | 4.2 Million USD | -11.93% |
| 2008 Q1 | 4.77 Million USD | 6.94% |
| 2008 Q3 | 3.67 Million USD | -12.55% |
| 2008 Q4 | 3.25 Million USD | -11.48% |
| 2008 FY | 3.25 Million USD | -27.09% |
| 2007 Q3 | 6.14 Million USD | -3.12% |
| 2007 Q2 | 6.34 Million USD | 1.73% |
| 2007 Q1 | 6.23 Million USD | -11.84% |
| 2007 Q4 | 4.46 Million USD | -27.37% |
| 2007 FY | 4.46 Million USD | -36.9% |
| 2006 Q3 | 7.65 Million USD | -6.33% |
| 2006 Q4 | 7.07 Million USD | -7.56% |
| 2006 FY | 7.07 Million USD | -28.06% |
| 2006 Q1 | 8.7 Million USD | -11.48% |
| 2006 Q2 | 8.17 Million USD | -6.14% |
| 2005 Q3 | 10.84 Million USD | 16.37% |
| 2005 FY | 9.83 Million USD | 2.63% |
| 2005 Q4 | 9.83 Million USD | -9.25% |
| 2005 Q2 | 9.31 Million USD | 1.73% |
| 2005 Q1 | 9.15 Million USD | -4.46% |
| 2004 Q4 | 9.58 Million USD | 7.35% |
| 2004 FY | 9.58 Million USD | 89.54% |
| 2004 Q1 | 6.82 Million USD | 34.95% |
| 2004 Q2 | 7.25 Million USD | 6.27% |
| 2004 Q3 | 8.92 Million USD | 23.11% |
| 2003 FY | 5.05 Million USD | 8.44% |
| 2003 Q4 | 5.05 Million USD | -0.13% |
| 2003 Q1 | 4.67 Million USD | 0.24% |
| 2003 Q2 | 3.95 Million USD | -15.4% |
| 2003 Q3 | 5.06 Million USD | 28.04% |
| 2002 Q1 | 4.19 Million USD | 12.53% |
| 2002 Q2 | 4.7 Million USD | 12.19% |
| 2002 Q4 | 4.66 Million USD | 8.76% |
| 2002 Q3 | 4.28 Million USD | -8.82% |
| 2002 FY | 4.66 Million USD | 25.19% |
| 2001 Q3 | 4.69 Million USD | -6.31% |
| 2001 Q4 | 3.72 Million USD | -20.57% |
| 2001 FY | 3.72 Million USD | 5.35% |
| 2001 Q2 | 5 Million USD | 13.57% |
| 2001 Q1 | 4.4 Million USD | 24.65% |
| 2000 FY | 3.53 Million USD | -15.81% |
| 2000 Q4 | 3.53 Million USD | -4.17% |
| 2000 Q3 | 3.69 Million USD | 8.53% |
| 2000 Q2 | 3.4 Million USD | -8.11% |
| 2000 Q1 | 3.7 Million USD | -11.9% |
| 1999 Q3 | 5.3 Million USD | 17.78% |
| 1999 Q1 | 3.5 Million USD | 0.0% |
| 1999 FY | 4.2 Million USD | 20.0% |
| 1999 Q4 | 4.2 Million USD | -20.75% |
| 1999 Q2 | 4.5 Million USD | 28.57% |
| 1998 Q4 | 3.5 Million USD | -14.63% |
| 1998 FY | 3.5 Million USD | 2.94% |
| 1998 Q1 | 3.1 Million USD | -8.82% |
| 1998 Q2 | 3.6 Million USD | 16.13% |
| 1998 Q3 | 4.1 Million USD | 13.89% |
| 1997 Q2 | 5.7 Million USD | 18.75% |
| 1997 Q4 | 3.4 Million USD | -40.35% |
| 1997 Q1 | 4.8 Million USD | 33.33% |
| 1997 Q3 | 5.7 Million USD | 0.0% |
| 1997 FY | 3.4 Million USD | -5.56% |
| 1996 Q1 | 2.5 Million USD | 8.7% |
| 1996 FY | 3.6 Million USD | 56.52% |
| 1996 Q4 | 3.6 Million USD | 28.57% |
| 1996 Q3 | 2.8 Million USD | 12.0% |
| 1996 Q2 | 2.5 Million USD | 0.0% |
| 1995 Q2 | 2.5 Million USD | 4.17% |
| 1995 Q1 | 2.4 Million USD | -14.29% |
| 1995 Q3 | 2.9 Million USD | 16.0% |
| 1995 Q4 | 2.3 Million USD | -20.69% |
| 1995 FY | 2.3 Million USD | -17.86% |
| 1994 Q4 | 2.8 Million USD | -9.68% |
| 1994 FY | 2.8 Million USD | -3.45% |
| 1994 Q3 | 3.1 Million USD | 3.33% |
| 1994 Q1 | 2.9 Million USD | 0.0% |
| 1994 Q2 | 3 Million USD | 3.45% |
| 1993 Q1 | 4.2 Million USD | 31.25% |
| 1993 Q2 | 4.6 Million USD | 9.52% |
| 1993 Q3 | 4.8 Million USD | 4.35% |
| 1993 Q4 | 2.9 Million USD | -39.58% |
| 1993 FY | 2.9 Million USD | -9.38% |
| 1992 Q3 | 4.3 Million USD | 10.26% |
| 1992 FY | 3.2 Million USD | 6.67% |
| 1992 Q1 | 6.3 Million USD | 110.0% |
| 1992 Q2 | 3.9 Million USD | -38.1% |
| 1992 Q4 | 3.2 Million USD | -25.58% |
| 1991 Q1 | 4.3 Million USD | 4.88% |
| 1991 Q4 | 3 Million USD | -28.57% |
| 1991 Q2 | 4.2 Million USD | -2.33% |
| 1991 FY | 3 Million USD | -26.83% |
| 1991 Q3 | 4.2 Million USD | 0.0% |
| 1990 Q4 | 4.1 Million USD | -28.07% |
| 1990 Q3 | 5.7 Million USD | -14.93% |
| 1990 FY | 4.1 Million USD | -42.25% |
| 1990 Q2 | 6.7 Million USD | 0.0% |
| 1989 FY | 7.1 Million USD | 20.34% |
| 1989 Q4 | 7.1 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | 17.963% |
| BrainsWay Ltd. | 3.71 Million USD | 26.945% |
| Cerus Corporation | 39.86 Million USD | 93.189% |
| Envoy Medical, Inc. | 1.4 Million USD | -93.407% |
| electroCore, Inc. | 2.16 Million USD | -25.715% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -494.188% |
| IceCure Medical Ltd | 2.27 Million USD | -19.36% |
| Inogen, Inc. | 21.84 Million USD | 87.567% |
| OrthoPediatrics Corp. | 105.85 Million USD | 97.435% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -876.777% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -271544000.0% |
| MaxCyte, Inc. | 12.22 Million USD | 77.795% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -57.263% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -1635.993% |
| Orthofix Medical Inc. | 222.16 Million USD | 98.778% |
| PAVmed Inc | 1.01 Million USD | -167.005% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | 86.396% |
| RxSight, Inc. | 17.42 Million USD | 84.413% |
| Sight Sciences, Inc. | 7.84 Million USD | 65.404% |
| SI-BONE, Inc. | 20.24 Million USD | 86.59% |
| TELA Bio, Inc. | 13.16 Million USD | 79.369% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | 90.715% |
| Vivos Therapeutics, Inc. | 1.00 USD | -271544000.0% |
| Acutus Medical, Inc. | 4.27 Million USD | 36.525% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -1080.627% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -15.256% |
| CVRx, Inc. | 10.98 Million USD | 75.276% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -596.131% |
| Bioventus Inc. | 91.33 Million USD | 97.027% |
| Venus Concept Inc. | 28.67 Million USD | 90.531% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -6.697% |
| LivaNova PLC | 147.88 Million USD | 98.164% |
| 908 Devices Inc. | 14.93 Million USD | 81.822% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 98.016% |
| Nemaura Medical Inc. | 1.75 Million USD | -54.739% |
| NeuroPace, Inc. | 11.21 Million USD | 75.785% |
| LENSAR, Inc. | 15.68 Million USD | 82.692% |
| Apyx Medical Corporation | 9.92 Million USD | 72.635% |
| Cutera, Inc. | 72.1 Million USD | 96.234% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | -1.588% |
| BioSig Technologies, Inc. | -103 Thousand USD | 2736.35% |
| Anika Therapeutics, Inc. | 46.38 Million USD | 94.146% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | 65.675% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 99.303% |
| Axonics, Inc. | 79.94 Million USD | 96.603% |
| Outset Medical, Inc. | 49.21 Million USD | 94.482% |
| IRIDEX Corporation | 9.9 Million USD | 72.588% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | 93.17% |
| IRadimed Corporation | 12.82 Million USD | 78.821% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -259.185% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -926.605% |
| Telesis Bio, Inc. | 4.02 Million USD | 32.536% |
| Viemed Healthcare, Inc. | 4.6 Million USD | 41.024% |
| Varex Imaging Corporation | 277.5 Million USD | 99.021% |
| Quipt Home Medical Corp. | 18.32 Million USD | 85.182% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | 83.782% |
| Dynatronics Corporation | 5.59 Million USD | 51.458% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | 27.414% |
| Semler Scientific, Inc. | 445 Thousand USD | -510.211% |
| InMode Ltd. | 45.09 Million USD | 93.978% |
| Bruker Corporation | 968.3 Million USD | 99.72% |
| Cytosorbents Corporation | 3.68 Million USD | 26.213% |
| DexCom, Inc. | 559.6 Million USD | 99.515% |
| Align Technology, Inc. | 296.9 Million USD | 99.085% |
| Viveve Medical, Inc. | 1.47 Million USD | -84.473% |
| ZimVie Inc. | 79.6 Million USD | 96.589% |
| Movano Inc. | 1.51 Million USD | -79.474% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 95.539% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -1635.993% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 98.281% |
| Profound Medical Corp. | 6.95 Million USD | 60.947% |
| Insulet Corporation | 402.6 Million USD | 99.326% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | 81.701% |
| iCAD, Inc. | 917 Thousand USD | -196.122% |
| Nuwellis, Inc. | 1.99 Million USD | -35.976% |
| Biotricity, Inc. | 1.87 Million USD | -44.484% |
| iRhythm Technologies, Inc. | 13.97 Million USD | 80.567% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -28.938% |
| PAVmed Inc. | 1.01 Million USD | -167.005% |
| BIOLASE, Inc. | 11.43 Million USD | 76.249% |
| Beyond Air, Inc. | 2.12 Million USD | -27.665% |
| AxoGen, Inc. | 23.02 Million USD | 88.204% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | 87.946% |
| Inari Medical, Inc. | 42.9 Million USD | 93.67% |
| UFP Technologies, Inc. | 70.19 Million USD | 96.131% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -331.585% |
| Tenon Medical, Inc. | 554 Thousand USD | -390.152% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -63.116% |
| AdaptHealth Corp. | 113.64 Million USD | 97.611% |
| Sintx Technologies, Inc. | 888 Thousand USD | -205.793% |
| NanoVibronix, Inc. | 2.73 Million USD | 0.606% |
| Quanterix Corporation | 22.36 Million USD | 87.859% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | 81.711% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | 95.209% |
| TransMedics Group, Inc. | 44.23 Million USD | 93.861% |
| ReWalk Robotics Ltd. | 5.65 Million USD | 51.965% |
| NeuroMetrix, Inc. | 1.55 Million USD | -74.131% |
| Hyperfine, Inc. | 6.58 Million USD | 58.744% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 96.603% |
| Biomerica, Inc. | 2.37 Million USD | -14.286% |
| Bone Biologics Corporation | -328.84 Thousand USD | 925.754% |
| AVITA Medical, Inc. | 3.12 Million USD | 13.006% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | 90.911% |